MTOR and cancer: To verify an on-target activity of the brain penetrant dual PI3K/mTOR inhibitor GNE-31722in vivo, we performed intravital microscopy and could demonstrate a specific PAM pathway inhibition in metastasizing cancer cells in the live mouse brain (Figure 4A).